Applications of Tetrahydropalmatine Hydrochloride in Industrial Manufacturing

As a direct producer of Tetrahydropalmatine Hydrochloride, we supply this specialty alkaloid to several regulated downstream sectors. Below, we outline key application fields with specific integration, compliance, formulation, and product channels unique to each industry.

1. Pharmaceutical Active Pharmaceutical Ingredient (API) Manufacturing

Pharmaceutical companies primarily utilize Tetrahydropalmatine Hydrochloride for formulating pain relief, sedative, and anxiolytic drugs. Process engineers dose the compound into blending tanks during the API production phase. Quality control conforms to pharmacopeial analysis, particularly to maintain assay and impurity profiles specified by regulators. The raw material enters as a crystallized solid and dissolves in ethanol or water under controlled temperature, before further purification or direct tableting. Finished APIs are granulated, compressed to tablets or encapsulated, strictly adhering to GMP. Processors adjust feed ratios per final dose requirements, with validated scales in commercial batch manufacturing facilities.

Industry compliance standards

• Chinese Pharmacopoeia (ChP) API monograph
• Good Manufacturing Practice (GMP) for APIs (ICH Q7 / CFDA GMP)
• EU GMP EudraLex Vol. 4 (APIs for medicinal use)
• FDA 21 CFR 210/211 for finished pharmaceutical production (if exported to USA)

Typical usage ratio

• 0.1%–1.5% w/w depending on dosage strength and solvent media
• Common commercial scale ratios: 10–200 kg per batch in direct blending
• Adjustment according to target dosage form (tablet, capsule, injectable solution)
• Analytical checks to confirm content uniformity per batch

Downstream process integration

• Batchwise dissolution in ethanol, isopropanol, or purified water
• Pilot or commercial blending with excipients in high-speed mixers
• Compression, encapsulation, or lyophilization depending on formulation
• In-process QC and post-production HPLC/UV-Vis analysis

Final product types

• Pain-relief tablets and capsules
• Anxiolytic solid dosage forms
• Oral solutions and injectable preparations (subject to registration and market authorization)
• Bulk API shipments for further secondary manufacture

2. Herbal Medicinal Extract Standardization

Nutraceutical and traditional Chinese medicine (TCM) extractors source Tetrahydropalmatine Hydrochloride for reference marker standardization in bulk herbal formulations, such as Corydalis tuber extracts. Analysts spike samples with the pure salt to calibrate HPLC and mass spectrometry traces, ensuring quantification matches regulatory requirements for active content. Production lines integrate the raw material at the quality control verification and blending stages, particularly before extract concentration and spray-drying. End customers require accurate labels on herbal sachets and capsules to comply with food and drug safety law, necessitating precise, documented integration of the ingredient.

Industry compliance standards

• Chinese Pharmacopoeia (herbal standards and marker control limits)
• ISO 22000 / HACCP for food-grade nutraceutical manufacturing
• CFDA regulations for herbal medicine and health supplements
• Lot-to-lot consistency SOPs for B2B extract supply

Typical usage ratio

• 0.05%–0.2% (calibration marker for HPLC/MS in extract batches)
• 0.02%–0.3% as blending material by mass for standardized extract products
• Adjustment based on marker content in source plant and local regulatory limits on alkaloid concentration
• Laboratory spikes: 10–100 mg per 1 kg sample for method validation

Downstream process integration

• Spiking herbal extracts at laboratory and pilot plant stages
• Homogenization in liquid or powder extract streams before granulation
• Batch blending with bulking agents and excipients before packaging
• Documentation and traceability recording for export and CFDA submissions

Final product types

• Standardized TCM extract powders
• Bottled liquid herbal solutions
• Filled sachets and capsules for nutraceutical brands
• Reference standard vials for B2B laboratory use

3. Analytical Reference Standards in Chemical and Pharmaceutical Laboratories

Analytical laboratories, both in industry and state-run institutes, use Tetrahydropalmatine Hydrochloride as a reference standard for the qualitative and quantitative determination of alkaloid content in plant materials or pharmaceutical products. Our cGMP production ensures a high purity level, critical for calibration of analytical instruments, method validation, and proficiency testing between laboratories. Lab chemists dissolve the crystalline ingredient directly in HPLC-grade solvents, then prepare working standards for calibration curves required in regulatory inspections, product release, and contamination screening.

Industry compliance standards

• Chinese Pharmacopoeia reference material requirements
• ISO/IEC 17025 for accredited analytical laboratories
• GLP (Good Laboratory Practice) documentation and traceability protocols
• USP/EP reference standard guidelines for method validation

Typical usage ratio

• Concentration: 10–100 μg/mL in calibration standard solutions
• Stock solution prep: 1–50 mg in 10–100 mL HPLC-grade methanol or acetonitrile
• Adjustment for method sensitivity and linearity requirements
• Replicate injections per assay to ensure accuracy and precision

Downstream process integration

• Weighing and dissolving in analytical-grade solvents for HPLC/GC/LC-MS
• Working standard preparation for calibration curves
• Routine quality control checks in sample throughput labs
• Stability and purity verifications prior to analytical method deployment

Final product types

• Sealed ampoules of certified reference materials
• Internal laboratory standard solutions
• Calibration kits for third-party testing labs
• Proficiency testing ring trial samples for industrial QC

4. Veterinary Pharmaceutical Formulations

Veterinary pharmaceutical manufacturers formulate pain management and light sedative products for livestock using this alkaloid salt. Production engineers blend the raw material into carrier premixes in GMP-certified facilities, monitoring content to conform to species-specific dosage requirements. It enters batch mixing during premix preparation, either for direct tableting or suspension formulations. Regulatory authorities require all raw ingredient integration steps, packaging, and release testing strictly documented and auditable, with clear animal-use labelling. Formulators customize the ratio per animal weight and intended use (oral or injectable), routinely validating batch content with in-house validated analytical methods.

Industry compliance standards

• Chinese Veterinary Pharmacopoeia (ChVP) ingredient monographs
• Veterinary GMP (Ministry of Agriculture - P.R.C.)
• Region-specific animal health product registration (EU Regulation (EU) 2019/6 for veterinary medicinal products)
• Veterinary product labelling and traceability rules (China, APAC, EU)

Typical usage ratio

• Dosage: 0.01%–0.2% in final formulation, adjusted for animal species and administration method
• Pilot batches: 50–500 g per 100 kg premix for oral products
• Ratio adjusted following documented clinical studies and local regulatory maximum residue limits (MRL)
• QC confirmed by HPLC prior to bulk packaging

Downstream process integration

• First blended into carrier solids or suspended in liquid bases
• Processed through granulator or homogenizer for uniform active distribution
• Packaged in single-dose or multi-dose veterinary bottles and sachets
• In-process and finished product testing for label claim compliance

Final product types

• Oral veterinary tablets or boluses for livestock
• Liquid suspensions for oral dosing devices
• Bulk premix agents for customized animal nutrition producers
• Veterinarian-labeled single- and multi-dose packs